Enhancement of reserpine-elicited dopaminergic supersensitivity by repeated treatment with apomorphine and alpha-methyl-p-tyrosine.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012110:Reserpine / Q000494:pharmacology*; D012601:Scopolamine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013569:Synapses / Q000187:drug effects
D008781:Methyltyrosines; D011955:Receptors, Drug; D012110:Reserpine; D012601:Scopolamine; D001058:Apomorphine; D004298:Dopamine